H.R. 5260 · 117th Congress · House

Reduced Costs and Continued Cures Act

Active· Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
Introduced
Sep 14, 21
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending
H.R. 5237
117th Congress
Reduced Costs and Continued Cures Act of 2021

Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.

Related bill
by CRS
Nov 1, 2022
H.R. 5237
117th Congress
Reduced Costs and Continued Cures Act of 2021

Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.

Related bill
by CRS
Nov 1, 2022
S. 1428
117th Congress
Preserve Access to Affordable Generics and Biosimilars Act

Placed on Senate Legislative Calendar under General Orders. Calendar No. 180.

Related bill
by CRS
Dec 9, 2021
S. 1428
117th Congress
Preserve Access to Affordable Generics and Biosimilars Act

Placed on Senate Legislative Calendar under General Orders. Calendar No. 180.

Related bill
by CRS
Dec 9, 2021
H.R. 2884
117th Congress
Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act

Ordered to be Reported in the Nature of a Substitute by Voice Vote.

Related bill
by CRS
Sep 30, 2021
H.R. 2884
117th Congress
Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act

Ordered to be Reported in the Nature of a Substitute by Voice Vote.

Related bill
by CRS
Sep 30, 2021
H.R. 2873
117th Congress
Affordable Prescriptions for Patients Through Promoting Competition Act of 2021

Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 27 - 16.

Related bill
by CRS
Sep 29, 2021
H.R. 2891
117th Congress
Preserve Access to Affordable Generics and Biosimilars Act

Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 28 - 13.

Related bill
by CRS
Sep 29, 2021
H.R. 2891
117th Congress
Preserve Access to Affordable Generics and Biosimilars Act

Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 28 - 13.

Related bill
by CRS
Sep 29, 2021
H.R. 2873
117th Congress
Affordable Prescriptions for Patients Through Promoting Competition Act of 2021

Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 27 - 16.

Related bill
by CRS
Sep 29, 2021
S. 1435
117th Congress
Affordable Prescriptions for Patients Act of 2021

Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.

Related bill
by CRS
Jul 29, 2021
S. 1435
117th Congress
Affordable Prescriptions for Patients Act of 2021

Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.

Related bill
by CRS
Jul 29, 2021
H.R. 4417
117th Congress
Capping Drug Costs for Seniors Act of 2021

Referred to the Subcommittee on Health.

Related bill
by CRS
Jul 14, 2021
H.R. 4417
117th Congress
Capping Drug Costs for Seniors Act of 2021

Referred to the Subcommittee on Health.

Related bill
by CRS
Jul 14, 2021
S. 2327
117th Congress
Seniors Prescription Drug Relief Act

Read twice and referred to the Committee on Finance.

Related bill
by CRS
Jul 13, 2021
S. 2327
117th Congress
Seniors Prescription Drug Relief Act

Read twice and referred to the Committee on Finance.

Related bill
by CRS
Jul 13, 2021
H.R. 2855
117th Congress
Star Rating for Biosimilars Act

Referred to the Subcommittee on Health.

Related bill
by CRS
Apr 27, 2021
H.R. 2855
117th Congress
Star Rating for Biosimilars Act

Referred to the Subcommittee on Health.

Related bill
by CRS
Apr 27, 2021
H.R. 2706
117th Congress
Freedom from Price Gouging Act

Referred to the Subcommittee on Health.

Related bill
by CRS
Apr 21, 2021
H.R. 2706
117th Congress
Freedom from Price Gouging Act

Referred to the Subcommittee on Health.

Related bill
by CRS
Apr 21, 2021